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The immune and nervous systems are two major organ systems responsible for host defense
and memory. Both systems achieve memory and learning that can be retained, retrieved, and
utilized for decades. Here, we report the surprising discovery that peripheral sensory neurons
of the dorsal root ganglia (DRGs) of immunized mice contain antigen-specific antibodies.
Using a combination of rigorous molecular genetic analyses, transgenic mice, and adoptive
transfer experiments, we demonstrate that DRGs do not synthesize these antigen-specific
antibodies, but rather sequester primarily IgG1 subtype antibodies. As revealed by RNAseq and targeted quantitative PCR (qPCR), dorsal root ganglion (DRG) sensory neurons
harvested from either naïve or immunized mice lack enzymes (i.e., RAG1, RAG2, AID, or
UNG) required for generating antibody diversity and, therefore, cannot make antibodies.
Additionally, transgenic mice that express a reporter fluorescent protein under the control of
Igγ1 constant region fail to express Ighg1 transcripts in DRG sensory neurons. Furthermore,
neural sequestration of antibodies occurs in mice rendered deficient in neuronal Rag2, but
antibody sequestration is not observed in DRG sensory neurons isolated from mice that lack
mature B cells [e.g., Rag1 knock out (KO) or μMT mice]. Finally, adoptive transfer of Rag1deficient bone marrow (BM) into wild-type (WT) mice or WT BM into Rag1 KO mice revealed
that antibody sequestration was observed in DRG sensory neurons of chimeric mice with WT
BM but not with Rag1-deficient BM. Together, these results indicate that DRG sensory neurons sequester and retain antigen-specific antibodies released by antibody-secreting plasma
cells. Coupling this work with previous studies implicating DRG sensory neurons in regulating
antigen trafficking during immunization raises the interesting possibility that the nervous
system collaborates with the immune system to regulate antigen-mediated responses.
Keywords: DRG, sensory neurons, antibodies, neural circuits, inflammation
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INTRODUCTION

immunized animals contained abundant levels of antigen-specific
antibodies. While others have reported the localization of antibodies to neurons in brain, to our knowledge, the localization of
antibodies to sensory neurons in peripheral tissues has not been
previously described. Rag2 expression has been identified in brain
neurons, but convincing evidence that neurons can synthesize
antigen-specific antibodies is lacking. Accordingly, here we used
molecular genetic analyses, and transgenic and chimeric mice to
show for the first time that dorsal root ganglion (DRG) sensory
neurons in immunized animals accumulate lymphocyte-derived,
antigen-specific IgG1.

The mammalian immune system has acquired capacity to recall
prior exposure to a vast number of potential antigens during
the lifetime of the host. The development of this long-lasting
immunity begins in a lymph node as an acute encounter between
a naïve T cell and an antigen presenting cell. T and B lymphocytes
recirculate between the lymphatic fluid, lymph node, and blood,
entering the lymph node through high endothelial venules. Once
inside the node, lymphocytes migrate through the T-cell zone
and B-cell follicles until encountering an antigen presented by
CD169+ macrophages or other antigen-presenting dendritic cells
(1). The temporal and spatial control of antigen transport into the
lymph node is dependent upon both the flow of isolated antigen
via afferent lymphatic channels, and the trafficking into lymph
nodes of intracellular antigen in antigen-presenting cells (APCs).
Significant changes in lymph node architecture, inhibition of lymphocyte egress, and expansion of the lymph node stroma occur
following antigen-mediated activation of intranodal immune
responses.
We recently discovered that neural signals provide an essential
mechanism in lymph nodes to retain antigen and lymphocytes
(2). Lymph nodes are innervated by both sensory (afferent) and
motor (efferent) neurons, with abundant innervation of the APCs
in the T-cell zone, subsinoidal layer, and cortical extrafollicular
zones (3, 4). The neuronal density within the lymph nodes is
dynamic, expanding significantly following antigenic stimulation
of an early lymphocyte response (5, 6). In naïve mice exposed
to the antigen keyhole limpet hemocyanin (KLH) in the hind
paw for the first time, we observed that KLH flowed rapidly
from the popliteal lymph node (adjacent to the injection site)
to the sciatic lymph node by traveling up the lymphatic chain.
Surprisingly, prior exposure to KLH significantly impaired the
flow of KLH from the popliteal to the sciatic lymph node during
subsequent antigen exposure. This restriction of antigen flow
from distal to proximal lymph nodes was antigen-specific and
required functioning sensory neural signals, because inhibiting
neural signals to the lymph node region restored antigen flow in
immunized animals (2). The neural mechanism that restricted
antigen flow is mediated by a subset of NaV1.8+ sensory neurons,
which include nociceptors, because antigen failed to accumulate in the distal lymph node of animals rendered deficient in
NaV1.8+ neurons (2). Early work had previously established that
immune complexes can interact via Fc receptors expressed on
sensory neurons to induce intracellular signaling mechanisms
that require transient receptor potential canonical 3 (TRPC3)
channel and the Syk-PLC-IP3 pathway (7, 8) that mediates the
release of calcitonin gene-related peptide (CGRP) and substance
P (9). Immunohistochemistry using labeled antigen revealed
colocalization of labeled antigen and FcγRI receptors in neurons
at the site of antigen injection in the paw (2). Thus together, these
studies implicate sensory neurons in regulating antigen trafficking during immunization through a pathway that requires NaV1.8
and FcγR.
As we continued to explore the role of sensory neurons in
immunization, we were very surprised to observe that sensory
neurons obtained from the dorsal root ganglia (DRGs) of
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MATERIALS AND METHODS
Animals

Six- to eight-week old male C57BL/6J (CD45.2), congenic
B6.SJL-PtprcaPepcb/BoyJ (also known as CD45.1;B6 Cd45.1, Pep
Boy; or Ly5.1), B6.129S7-Rag1tm1Mom/J [also known as Rag1 knock
out (KO)]; B6.129P2(Cg)-Ighg1tm1(cre)Cgn/J (Cγ1-cre), B6.CgGt(ROSA)26Sortm14(CAG-tdTomato)Hze/J (Ai14(RCL-tdT)-D), C57BL/6Rag2tm1Cgn/J (Rag2 flox), and B6.Cg-Tg(Syn1-cre)671Jxm/J and
B6.129S2-Ighmtm1Cgn/J (μMT) mice were purchased from the
Jackson Laboratory (Bar Harbor, ME, USA). Syn1-cre mice were
crossed to Rag2flox/flox mice to generate Syn-cre/Rag2 flox/+. Syn1-cre/
Rag2flox/+ mice were backcrossed to Rag2flox/flox mice to generate
Syn1-cre/Rag2flox/flox (Rag2KO) mice. To generate Ighg1-tdTomato
mice, B6.129P2(Cg)-Ighg1tm1(cre)Cgn/J mice were bred with tdTomato reporter mice (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J).
Mice were housed in the animal facility of the Feinstein Institute
for Medical Research under standard temperature and 12 h light
and dark cycles. All mice were allowed to acclimate for at least
7 days before experimentation. All protocols used in this study
involving animals were approved by the Institutional Animal
Care and Use Committee (IACUC) of the Feinstein Institute for
Medical Research, and all experimentation was in accordance
with the National Institutes of Health guidelines for animal care
(Guide for the Care and Use of Laboratory Animals, National
Research Council 2011).

Generation of Chimeric Mice

The recipient mice were sub-lethally irradiated with two split
doses (WT: 5 Gy; Rag1 KO: 4 Gy) delivered 14 h apart, and
their immune systems were rescued via BM transplantations
from Rag1 KO (CD45.2) or WT (CD45.1) mice, respectively.
Antibiotic gel diet (MediGel® TMS) was given to animals
before and after irradiation. Donor mice were euthanized by
CO2 asphyxiation/cervical dislocation, and the femur and tibia
were harvested. BM cells were collected by gently flushing the
femurs and tibia and suspended at a concentration of 2 × 106
cells in 200 µL of sterile Hank’s balanced salt solution (HBSS).
Cells were administered intravenously (retro-orbital injection)
to recipient mice 4–5 h after the second dose of irradiation.
Reconstitution of the BM in recipient mice was confirmed after
2–4 weeks by assessing numbers of CD45.1 or CD45.2-positive
cells in the peripheral blood by flow cytometry (reconstitution
was >98%).
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Immunization Protocols

laser scanning confocal microscope (Carl Zeiss) using X40 Zeiss
plan-apochromatic oil objective with Z stacks. The numbers of
NeuN-positive and NeuN-positive IgG-positive neurons were
quantified in five DRG sections pooled from three animals using
ImageJ. The percentages of IgG-positive neurons were quantified
by counting the number of neurons double positive for IgG and
NeuN divided by the total NeuN-positive neurons in each DRG
section and then multiplied by 100.

For all immunohistochemical staining of DRGs, RNA-seq, and
ELISpot assays, mice were injected intraperitoneally with either
50% alum (Imject™ Alum; Thermo Fisher Scientific, Waltham,
MA, USA) or 50% alum + 100 µg KLH (Calbiochem, San Diego,
CA, USA) or 50% alum + 100 µg ovalbumin (OVA; Invivogen,
San Diego, CA, USA) in 200 µl of 0.9% saline on day 0 and day
14. DRGs were harvested 14 days later (see below). For in vivo
analysis of gene expression by quantitative PCR (qPCR), mice
were injected with either 50% alum or 50% alum + 100 µg KLH
in 200 µl of 0.9% saline on days 0, 14, and 28, and DRGs were
collected 24 h post each injection.

Primary Cultures of Isolated DRG Sensory
Neuron Preparations

Dorsal root ganglion neuron preparations were cultured in complete neurobasal medium [neurobasal™ medium supplemented
with penicillin-streptomycin (Gibco), GlutaMax™ (Gibco),
B-27® serum-free supplement (Gibco), 50 ng/ml NGF (SigmaAldrich), 10% fetal bovine serum, and 1× β-mercaptoethanol] for
DRG neuron activation assays (see below).

Collection of Whole DRGs and Isolation of
Sensory Neuron Preparations

Dorsal root ganglia from thoracic and lumbar regions were
harvested from mice immediately following euthanasia by CO2
asphyxiation. DRGs from the thoracic and lumbar regions were
chosen because they have been shown to innervate the peritoneal
cavity (10). DRGs were gently collected from the cavities along
the lateral vertebral column as described previously (11) and
enriched for neuronal populations, as described by Ref. (12).
For the isolation of sensory neurons, DRGs were digested with
1 µg/ml collagenase/dispase (Roche Life Science, Germany) in
neurobasal medium (Gibco, Thermo Fisher Scientific, Waltham,
MA, USA) for 1 h at 37°C on a rotator-shaker. Following digestion, DRGs were washed with HBSS (Gibco), triturated using
fire-polished glass Pasteur pipettes (Fisher Scientific, Waltham,
MA), and filtered through a 70-µm strainer. The cell suspension
was layered onto 15% BSA in HBSS and centrifuged at ×129g
for 20 min without brake. The cell pellet was re-suspended in
neurobasal medium. B lymphocytes were depleted from cell
preparations using Dynabeads™ mouse pan B purification kit
(Invitrogen, USA), and cell purity was assessed by flow cytometry. The resulting sensory neuron preparation was resuspended
in complete neurobasal medium [neurobasal™ medium supplemented with penicillin-streptomycin (Gibco), GlutaMax™
(Gibco), B-27® serum-free supplement (Gibco), and 50 ng/ml
NGF (Sigma-Aldrich)].

ELISpot Assay

Dorsal root ganglion sensory neurons (isolated and prepared as
described above) were cultured on anti-IgG or OVA- or KLHcoated ELISPOT plates and developed using the standardized
ELISpot kit (Mabtech Inc., Cincinnati, OH, USA). Briefly, 96 well
flat bottom multi-screen filter plates (Millipore, Billerica, MA,
USA) were coated with 100 µL per well of KLH (50 µg/ml) or
OVA (50 µg/ml) or anti-IgG antibody (15 µg/ml). The plates were
incubated overnight at 4°C, washed with PBS, and blocked using
complete neurobasal medium. DRG sensory neurons (isolated
and prepared as described above from five mice per group for
eight wells) suspended in complete neurobasal medium were cultured in the plates overnight at 37°C with 5% CO2. ELISpots were
developed as per the manufacturer’s protocol and scanned and
analyzed at Cellular Technology Ltd. (Shaker Heights, OH, USA).

FluoroSpot Assay

Dorsal root ganglion sensory neurons (isolated and prepared as
described above) were cultured in anti-mouse IgG-coated plates
and incubated overnight at 37°C with 5% CO2. FluoroSpots
were developed using the fluorescent tagged mouse IgG1, IgG2a,
and IgG3 detection kit as per the manufacturer’s protocol
(Cellular Technology Ltd.) and scanned and analyzed at Cellular
Technology Ltd.

Immunohistochemical Staining

Whole mount DRGs were harvested from mice immediately after
euthanasia by CO2 asphyxiation as described above and fixed
with 4% PFA for 2 h. Fixed specimens were incubated overnight
in 30% sucrose/PBS, washed, embedded, and frozen in optimal
cutting temperature compound (Tissue-TEK OCT, Electron
Microscopy Sciences, VWR, Radnor, PA, USA). 14 µm thick
frozen sections were mounted on the Superfrost Plus glass slides
(Thermo Fisher Scientific). The tissue sections were blocked
and permeabilized with blocking solution containing rabbit
serum and 0.1% Triton X-100. For immunostaining, blocked/
permeabilized sections were stained with AlexaFluor 488-rabbit
F(ab′)2 anti-mouse IgG (H + L) (1:1,000; Abcam, San Francisco,
CA, USA), AlexaFluor 647-rabbit anti-NeuN (1:50; Abcam), and
DAPI. Sections were mounted in ProLong anti-fade mounting
medium (Thermo Fisher Scientific) and imaged using an LSM880

Frontiers in Immunology | www.frontiersin.org

In Vitro B Cell and DRG Neuron Activation
Studies

Splenic B cells were purified from 7- to 10-week-old naïve
C57BL/6 mice using the EasySep B Cell Isolation Kit (STEMCELL
Technologies, Cambridge, MA, USA). B cell purity (CD19positive cells) was confirmed (>99%) using flow cytometry.
Isolated B cells were cultured in complete DMEM containing
penicillin, streptomycin, glutamine, β-mercaptoethanol (1×
each) and 10% fetal bovine serum at 3 × 106 cells/ml per well (24
well plate) in duplicate. DRG neurons were isolated from naïve
C57BL/6 mice and depleted of B cells, as described above. DRG
neurons from five naïve mice were cultured in 0.25 ml per well
(48 well plate) in duplicate per condition in complete neurobasal
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media (described above) containing 10% fetal bovine serum and
1× β-mercaptoethanol. B cells and DRG neurons were stimulated
with (1) vehicle (untreated cells); (2) LPS (25 µg/ml) + IL-4
(10 ng/ml); and (3) anti-CD40 (10 µg/ml) + IL-4 (10 ng/ml).
B cells were harvested 24, 48, and 72 h post stimulation, and DRG
neurons were harvested 48, 72, 96, and 120 h post stimulation,
and markers of antibody production and the generation of plasmablasts/plasma cells were assessed by qPCR (e.g., Rag2, Aicda,
and Prdm-1, as described below; see Table 1 for primers).

aligned to the iGenome mm10 reference sequence from Illumina,
and gene expression was quantified using kallisto.1 Data are
reported as transcripts per million (TPM), which are considered
more comparable between samples of different origins and composition, and the most frequently reported RNA-seq gene expression values (13). An expression value >3.0 TPM (transcripts per
million) was used as a threshold for detectable expression. The
RNA-seq data discussed here have been deposited in the NCBI
Gene Expression Omnibus (GEO) (14) and are accessible through
GEO Series accession number GSE108428.2

RNA Isolation

RNA-Seq Deconvolution Analysis

Naïve mouse spleens (positive control) and DRG neuron preparations isolated from naïve, alum-injected, and alum + KLHimmunized mice (n = 10 mice per condition, pooled) were lysed
with Qiazol lysis reagent (Qiagen, Germantown, MD, USA) and
stored at −80°C until RNA preparation (DRG neurons from 10
mice yielded approximately 50 µg RNA). Spleen and DRG RNA
were isolated using the RNeasy Universal Kit (Qiagen). For the
in vitro activation assays (described above), RNA was isolated
from DRG neurons using the RNeasy Universal Kit (Qiagen) and
from B cells using the RNeasy Mini Kit (Qiagen). For RNA-seq
studies, RNA quality was analyzed using the Bioanalyzer (Agilent
Technologies, Santa Clara, CA, USA); RNA integrity numbers
(or RIN values) were approximately 8.0. All RNA samples had
OD260:OD280 ratios >1.8.

We utilized DeconRNASeq software (15) to perform RNAseq deconvolution analysis to infer cell type compositions of
the neuronal preparations isolated from alum-injected and
alum + KLH-immunized mice. DeconRNASeq, a freely available
software package written in R, was downloaded from http://
bioconductor.org/packages. DeconRNASeq uses a globally optimized non-negative decomposition algorithm for estimating the
relative proportions of distinctive cell types in a mixture sample.
High-quality pure cell-type signatures were derived from RNA
sequencing data on single cells from the mouse lumbar DRGs
(16). The data are available from the GEO (GSE59739), and the
normalized data expressed as reads per million (RPM) were
downloaded from http://linnarssonlab.org/drg/. This dataset
contains single cell RNA-seq measures of 799 cells as well as clustering assignments of 731 of these cells by principal component
analysis. The five principal cell classes included 109 non-neuronal
(NoN) cells, 81 peptidergic nociceptor (PEP) cells, 169 non-pep
(NP) cells, 139 neurofilament containing (NF) cells, and 233
tyrosine hydroxylases containing (TH) cells. We averaged the
RNA-seq measures for each of the five cell classes. We excluded
genes in which the mean RPKM (reads per kilobase of TPM
mapped reads) value for the cells types was below a 0.1 cutoff
value. There were 11,776 genes that passed this constraint and
were used in the deconvolution analysis. Using the deconvolution
analysis, we analyzed relative proportions of distinctive cell types
in our groups. Based on pure cell-type signatures, approximately
73% of our DRG neuron preparations were neuronal (Figure S1
in Supplementary Material). Of the cells with a neuronal origin,
three different neuronal subtypes were identified: peptidergic
nociceptor (PEP) cells, non-PEP (NP) cells, and NF (NF) cells.

RNA-Seq and Analysis

The sequencing mRNA libraries (for paired-end reads) were
prepared using RNA isolated from DRG neurons purified from
either alum-injected or alum + KLH-immunized C57BL/6J mice
(n = 10 mice per group, pooled) using the TruSeq Stranded
mRNA Sample Preparation Kit (Illumina, San Diego, CA, USA),
according to the manufacturer’s instructions. As an exploratory
step for characterizing the DRG neuron preparations, deep RNA
sequencing was performed on the Illumina NextSeq 500 platform.
The read depth was at least 60 M reads per sample using 75 base
pair paired-end reads for a total output of ~18 Gb. The raw image
files from the NextSeq sequencer were de-multiplexed and converted to fastq files using the bcl2fastq BaseSpace App (Illumina).
RNA-seq analysis was performed on the existing annotated reference transcriptome (mouse) – no alternate transcript discovery
was performed. Adapter sequences and low-quality base reads
were trimmed from fastq files using cutadapt. The fastq files were

Two Step Real-Time qPCR

Two step qPCR analysis was carried out to analyze the relative
expression of target genes in B cell-depleted DRG neuron preparations isolated from naïve, alum-injected and alum + KLHimmunized mice, spleens and whole DRG preparations (without
B cell depletion) isolated from naïve mice, as well as in vitro stimulated B cells and DRG neuron preparations (described above).
First, cDNA synthesis was performed using ~1.5 μg of RNA using
the ABI High-Capacity cDNA Reverse Transcription Kit (Thermo

TABLE 1 | Quantitative PCR (qPCR) primers and probes.
Gene name

Forward sequence

Reverse sequence

Rag1
Rag2
Aicda
Ungv1v2
Cd19
Cd138
Prdm1
Hprt1

aggcctgtggagcaaggta
tgaataaagatgtcaacagccaat
tcctgctcactggacttcg
ccatggggatttgtcagg
aaggtcattgcaaggtcagc
gagggctctggagaacaaga
cgctatgactttggtgcttg
tcctcctcagaccgctttt

gctcagggtagacggcaag
ggtaccctcaatccccactt
gcgtaggaacaacaattccac
acagtgaggacggcgttg
ctgggactatccatccacca
tgtggctccttcgtccac
accctcacctctgcactga
cctggttcatcatcgctaatc

Probe
46
29
71
101
21
5
108
95

1
http://www.nature.com/nbt/journal/v34/n5/full/nbt.3519.html
December 29, 2017).
2
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108428
December 29, 2017).

Forward and reverse primers and probes for indicated mouse genes (Roche Universal
ProbeLibrary); v1v2 = variant 1 variant 2.
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collected from naïve (untreated), alum-injected, or alum + KLHimmunized mice using a rabbit F(ab′)2 anti-mouse IgG (H+L)
antibody. The F(ab′)2 fragment against IgG has been used for
immunohistochemical staining because it is small and can penetrate tissues/cells, and does not bind to the Fc receptors expressed
on the target cells (18, 19). Mice were subjected to either sham
immunization, intraperitoneal injection with adjuvant (alum)
or immunization with alum + KLH. Animals received an intraperitoneal booster dose on day 14, and whole mount lumbar and
thoracic DRGs were isolated from naïve and immunized mice
after 4 weeks of immunization. Neuronal populations from DRG
sections were stained with labeled anti-NeuN antibodies that
recognize the neuronal nuclear protein NeuN. While only sparse
IgG-positive staining was observed within the NeuN-positive
DRG sensory neurons from the naïve and alum-injected animals, a significant increase in the number of double IgG-positive
NeuN-positive neurons was observed in DRGs collected from
alum + KLH-immunized mice (Figures 1A–C). Quantitative
analysis revealed that IgG-positive staining of the NeuN+ DRG
neurons was similar in naïve (3.5% ± 1.8%,) and alum-injected
mice (5.9% ± 4.1%) (Figure 1D, a total of 824 and 1,343 NeuN+
neurons were analyzed from naive and alum-injected mice,
respectively). By contrast, a significantly higher percentage of
NeuN+ DRG neurons stained for IgG following alum + KLH
immunization (23.8% ± 9.1%) (Figure 1D, P < 0.05, a total of
814 NeuN+ neurons were analyzed). NeuN is most abundant in

Fisher Scientific). Second, qPCR reactions were performed (up
to 35 cycles) in triplicate using the specific mouse primer pairs
and probes (Table 1) (Roche Universal ProbeLibrary), ~25 ng
cDNA per well in a 384-well plate using the Eurogentec qPCR
MasterMix (AnaSpec, Fremont, CA, USA) and the Roche 480
Light Cycler (Roche Diagnostics). All qPCR samples were run
in triplicate. Mouse Hprt1 was used as the housekeeping gene
for normalization. Changes in gene expression, normalized for
Hprt1 expression, were calculated as relative fold-changes using
the comparative Ct (ΔΔCt) method (17).

Statistical Analysis

GraphPad Prism 6.0 software was used for all statistical analysis.
Values are presented as mean ± SD. Kruskal–Wallis ANOVA,
followed by appropriate post hoc tests for multiple comparisons,
and Mann-Whitney non-parametric test (for two groups) were
performed to determine statistical significance. P values equal to
or below 0.05 were considered significant.

RESULTS
Detection of IgG in Sensory Neurons
of Mouse DRG

To study the accumulation of IgG in DRG sensory neurons, we
performed immunohistochemical analysis of whole mount DRGs

FIGURE 1 | Sensory neurons of the mouse dorsal root ganglia (DRGs) exhibit abundant IgG reactivity. Immunohistochemical staining of whole DRGs isolated
from (A) naïve, (B) alum-injected, and (C) alum + KLH-immunized C57BL/6J mice to detect neurons (NeuN, red), IgG (green), and nuclei (DAPI, blue). 400×
magnification; scale bar = 20 µm. (D) Percentage of double IgG-positive, NeuN-positive neurons (among total NeuN-positive neurons) in DRGs isolated from naïve,
alum-injected, and alum + KLH-immunized mice (n = 5 per group). A total number of 824, 1,343, and 814 NeuN+ DRG neurons were assessed for immunostaining
for the naïve, alum-treated and alum + KLH-immunized mice, respectively. Data are shown as mean percentage ± SD. *P < 0.05 vs naïve DRGs Kruskal–Wallis one
way ANOVA (followed by Dunn’s Multiple Comparison Test).
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the neuronal nucleus, and IgG protein is primarily distributed in
the cytoplasm of sensory neurons (Figures 1A–C).

agreement with our immunohistochemical data showing low
numbers of sensory neurons sequestering antibodies in DRGs
of alum-injected controls (Figure 1B). Similar to alum + KLHimmunization, a significant increase in number of neurons relea
sing total IgG and OVA-specific IgG was observed in DRGs
harvested from alum + OVA-immunized mice (Figures 2C,D).
As alum + KLH-immunized mice exhibited robust responses, we
utilized this model for our subsequent studies. The majority of
these DRG sensory neurons from alum + KLH-immunized mice
released IgG1 isotype (Figure 2E). To study the antigen specificity of the IgG associated with DRG sensory neurons, we next
assessed the number of IgG-releasing neurons in a KLH-specific
or an OVA-specific ELISpot assay. A significant increase in

Sensory Neurons From DRG Release
Antigen-Specific IgG1

To investigate the antigen-specificity of antibodies sequestered in
neurons, DRG sensory neurons were cultured on ELISpot plates.
A significant increase in the number of total IgG-releasing neurons
was observed in DRGs isolated from alum + KLH-immunized
mice as compared to alum-injected controls (Figures 2A,B). It is
interesting to note that fewer neurons releasing IgG were detected
in animals that received only alum (Figures 2A,B), which is in

FIGURE 2 | Dorsal root ganglion (DRG) neurons release antigen-specific IgG1. (A) Representative images from total IgG ELISpot assay performed on DRG neurons
isolated from alum-injected and alum + KLH-immunized mice. Quantitation of total IgG-releasing DRG neurons isolated from (B) alum-injected and alum + KLHimmunized mice (n = 5 per group) or (C) alum-injected and alum + ovalbumin (OVA)-immunized mice (n = 5 per group) using the ELISpot assay (mean ± SD);
**P < 0.01 vs. alum-injected (Mann-Whiteny test). (D) Quantitation of anti-OVA-releasing DRG neurons isolated from alum-injected and alum + OVA-immunized mice
(n = 5 per group) using the Anti-OVA IgG ELISpot assay (mean ± SD); **P < 0.01 vs. alum-injected (Mann-Whitney test). (E) Quantification of IgG1-, IgG2a-, and
IgG3-specific FluoroSpots from DRG neurons isolated from alum-injected and alum + KLH-immunized mice using the IgG isotype FluoroSpot assay; (mean ± SD,
n = 4 per group); *P < 0.05 vs. alum-injected (Mann-Whitney test). (F) Quantification of anti-OVA- and anti-KLH-specific IgG immunospots from DRG neurons
isolated from alum-injected and alum + KLH-immunized mice (mean ± SD, n = 4 per group) using the antigen-specific ELISpot assay; *P < 0.05 vs. alum-injected
for each antigen (Mann-Whitney test).
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KLH-specific neurons was observed in animals immunized with
alum + KLH as compared to alum-injected controls (Figure 2F).
In contrast, no anti-OVA IgG-releasing neurons were detected
in DRGs isolated from either alum-injected or alum + KLHimmunized mice (Figure 2F), indicating that antigen-specific
IgG antibodies are associated with DRG sensory neurons in
immunized animals.

validated by quantitative real-time RT-PCR. As expected, high
levels of the B cell marker, Cd19, and low-moderate levels of
Rag1, Rag2, Aicda, and Ung were observed in the naïve spleen.
However, DRG sensory neurons failed to express Rag1, Aicda or
Ung at any of the time points studied (Table 3). Our preliminary
RNA-seq data confirmed the expression of Il4ra (the gene that
encodes the alpha chain of the IL-4 receptor, a type I transmembrane protein that can bind IL-4 and IL-13 to regulate IgG
production) in DRG sensory neurons (TPM value ~5) and the
expression of the Tlr4 gene (that encodes the receptor for LPS)
(TPM value ~7). To address the possibility that the molecular
events related to antibody synthesis are not operative during the
DRG sample collection and analysis, but may be induced in a
similar manner as activated B cells, we stimulated DRG sensory
neurons (or splenic B cells as a positive control) in vitro and
assessed the expression of Rag2 and Aicda at three different time
points post-stimulation. We used two conditions for in vitro
activation of DRG sensory neurons and B cells: LPS + IL-4
(T-independent) or anti-CD40 + IL-4 (T-dependent) and no
treatment (vehicle). As reported previously (21, 22), stimulation of mature mouse B cells with LPS + IL-4 resulted in the
expression of both Rag2 and Aicda in vitro in a time-dependent
manner (Figure 3). In contrast, activation of DRG sensory neurons with either T-independent (LPS + IL-4) or T-dependent
(anti-CD40 + IL-4) stimuli failed to induce either Rag2 or Aicda
gene expression (Figure 3). These data confirm that DRG sensory neurons lack the expression of essential enzymes required
for IgG synthesis.

DRG Sensory Neurons Lack Expression
of Essential Enzymes Required for IgG
Synthesis

To assess if sensory neurons from DRGs have the molecular
machinery to synthesize antibodies and undergo class-switching,
we analyzed the transcriptome of the neuronal population using
RNA-seq. DRGs were harvested from animals immunized with
alum + KLH (n = 10) or alum-injected controls (n = 10) and
RNA-seq analysis was performed using the RNA prepared from
pooled DRG neurons for downstream processing to maximize
biological diversity. The RNA-seq analysis was primarily used to
evaluate the overall transcriptome of the DRG neuron preparations and not to statistically compare the alum vs. alum + KLHimmunized groups. As an exploratory step for characterizing
the DRG neuron preparations, RNA-seq was performed using
the Illumina NextSeq platform. An average of 17,355 and 17,030
genes were detected (detection > 3 transcripts per million, TPM)
in the two groups studied, alum-injected and alum + KLHimmunized, respectively.
Further examination of the RNA-seq data revealed that the
expression of neuronal and nociceptor-related gene expression
was present in the alum-injected and alum + KLH-immunized
groups (Table 2). In contrast, the expression of B lymphocyte,
T lymphocyte, mast cell, and basophil-related genes were not
observed in either of the groups. Both neuronal preparations
show a similar low level of positive regulatory domain zinc
finger protein-1 (Prdm1) expression (Table 2), which encodes
Blimp1, a protein required for the differentiation of B cells into
plasma cells (20). These data demonstrate that the enriched
neuronal preparation in our study is devoid of B lymphocytes.
We next evaluated whether the DRG sensory neuron populations express any of the essential genes required for antibody
synthesis and class-switching. No expression of Rag1, Rag2,
Aicda, or Ung genes was observed in either alum-injected or
alum + KLH-immunized group (Table 2), indicating that
DRG sensory neurons lack the genetic make-up to produce
antibodies.
To confirm the RNA-seq data, we validated the expression of
genes required for antibody synthesis and B cell differentiation
into plasmablasts/plasma cells at different time points postimmunization. DRG neuronal preparations were isolated from
animals (alum-injected controls or alum + KLH-immunized)
at three different time points (n = 10 mice per group): postprimary immunization, post-first booster and post-second
booster as described in the Section “Materials and Methods.”
The expression pattern of four genes related to antibody synthesis (Rag1, Rag2, Aicda, and Ung) and two genes corresponding
to B lymphocyte/plasma cell markers (Cd19 and Prdm1) were
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Transgenic Ighg1-tdTomato Mice Do Not
Express tdTomato in DRG Sensory
Neurons

Casola et al (23) have produced a transgenic Ighg1-cre mouse
that can be used in combination with a reporter gene to analyze
the transcription of Igγ1 constant region gene segment (Cγ1)
in antibody expressing cells. We utilized the Ighg1-cre mice to
induce expression of a fluorescent reporter protein, tdTomato,
in antibody-expressing cells because IgG1 was found to be the
most prominent subtype in the DRG neurons (Figure 2E). The
elimination of the STOP cassette and subsequent tdTomato
expression was achieved by crossing Ighg1-cre mice with B6.CgGt(ROSA)26Sor tm14(CAG-tdTomato)Hze/J mice, resulting in tdTomato
expression mostly in cells expressing Cγ1 and hence, IgG1.
Transgenic mice (carrying both cre and tdTomato) were indistinguishable from their WT littermate controls (carrying only
cre or tdTomato) in terms of developmental features. tdTomato
is one of the brightest among the red-fluorescent proteins and
well-suited for immunohistochemical analysis. Accordingly, we
found that the tdTomato reporter mice had increased numbers
of tdTomato + cells in their spleens following immunization
(Figure 4A). However, no colocalization of tdTomato fluorescent signal and antibody staining was observed in sensory
neurons following immunization (Figure 4B). As tdTomato
expression is driven by the transcription of Cγ1 (of IgG1), these
data confirm that Ighg1 are not expressed in sensory neurons
from DRG.
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TABLE 2 | Expression of neuron, non-neuron, Fc gamma receptor, and antibody recombination gene expression by DRGs.
Alum-TPM

Alum + KLH -TPM

Nestin
Neurofilament Heavy, NF200
Neurofilament Light, NF68
Neurofilament Medium, NF3
NeuN

22.40
1,020.71
5,259.31
2,262.77
54.34

22.48
973.48
5,048.04
2,181.69
37.77

NM_008737
NM_018733
NM_009135
NM_009134
NM_011887
NM_177781
NM_001001445
NM_011706

Neuropilin 2
Nav1.1
Nav2.1
Nav1.8
Nav1.9
TRPA1
TRPV1
TRPV2

91.98
140.59
693.59
293.78
374.29
153.92
72.59
10.51

94.94
161.37
694.48
276.91
330.16
130.88
73.55
7.61

B cell marker genes
Cd5
Cd19
Cd22
Ptprc
Prdm1

NM_007650
NM_009844
NM_009845
NM_011210
NM_007548

CD5
CD19
CD22
B220; CD45R
BLIMP1

0
0
0.79
0.44
3.79

0
0
0.76
0
3.07

T cell marker genes
Cd3e
Cd3g
Cd8a
Cd80

NM 007648
NM 009850
NM_001081110
NM_009855

CD3e
CD3y
CD8A
CD80

0.19
0
0
0.89

0.04
0
0
0.93

Basophil and mast cell genes
Cd200r3
Cd200r3
Cd200r3
Anpep
Il3ra

NM_029018
NM_001128132
NM_027578
NM_008486
NM_008369

CD200R3
CD200R3
CD200R3
CD13
IL-3Ra

0
0
0
0.13
0.19

0
0
0
0.16
0.04

Fc gamma receptor genes
Fcgr1
Fcgr2b
Fcgr2b
Fcgr3
Fcgr4
Fcgrt

NM_010186
NM 010187
NM 001077189
NM_010188
NM_144559
NM_010189

FcyR1
FcyR2b
FcyR2b
FcyR3
FcyR4
FcRn

0.07
5.67
0
0.3
4.32
2.31

0.04
4.44
0.66
0.3
3.97
1.40

Ab recombination genes
Aicda
Rag1
Rag2
Ung

NM_009645
NM_009019
NM_009020
NM_011677

AID
RAG1
RAG2
Uracil-DNA glycosylase (UNG)

0.05
0.08
0.61
1.27

0.02
0.06
0.56
0.71

Neuronal marker genes

RefSeq ID

Protein

Nes
Nefh
Nefl
Nefm
Rbfox3

NM_016701
NM_010904
NM_010910
NM_008691
NM_001285438

Nociceptor-related genes
Nrp2
Scn1a
Scn7a
Scn10a
Scn11a
Trpa1
Trpv1
Trpv2

For RNA-Seq: RNA was isolated from DRG neurons collected from alum-injected mice and alum + KLH-immunized mice (n = 10 animals per group – pooled). The values expressed
are TPM values for each pooled sample (without SDs). TPM, transcripts per million (relative abundance of gene expression based on the length of each gene and for sequencing depth).

DRG Sensory Neurons Lacking Neuronal
Rag2 Expression Contain Antigen-Specific
Antibodies

higher numbers of IgG-releasing and anti-KLH IgG-releasing
DRG neurons were observed in the alum + KLH group when
compared to the alum-injected group even in the absence of Rag2
expression (Figures 5C,D). Taken together, our results indicate
that sensory neurons from DRGs lack the enzymes and cannot
synthesize antibodies.

Because neuronal Rag2 expression has been implicated in previous work (24–27), here we crossed floxed-Rag2 transgenic mice
with synapsin-cre transgenic mice generating null mutants that
selectively lack Rag2 expression in neurons (with abundant Rag2
expression in B cells). Analysis of immunoglobulin reactivity in
the DRGs of null mutants revealed the presence of IgG-positive
NeuN-positive neurons in both alum-injected (Figure 5A) and
alum + KLH-immunized (Figure 5B) mice. Similar to previous
observations with WT mice (Figures 2A,B,F), significantly
Frontiers in Immunology | www.frontiersin.org

Antibodies Found in DRG Neurons Are
Released by B Cells

Accordingly, we reasoned that the neurons from DRGs sequester
and retain antibodies produced by plasma cells, and therefore,
DRGs isolated from mice incapable of producing B cell-derived
8
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TABLE 3 | In vivo analysis of gene expression by Q-PCR.
Day 0

Rag1
Rag2
Aicda
Ung
CD19
Prdm1

Day 14

Day 28

Alum

Alum + KLH

Alum

Alum + KLH

Alum

Alum + KLH

Naïve DRG

Naïve Spleen

1.0 ± 0.2
1.0 ± 0.4
1.0 ± 0.0
1.0 ± 0.1
1.0 ± 0.0
1.0 ± 0.1

2.0 ± 0.2
1.3 ± 0.6
0.0 ± 0.0
1.5 ± 0.2
0.4 ± 0.2
1.1 ± 0.2

0.6 ± 0.4
12.2 ± 3.1
0.0 ± 0.0
0.7 ± 0.2
0.8 ± 0.0
0.3 ± 0.0

0.6 ± 0.3
57.4 ± 9.9
0.0 ± 0.0
1.1 ± 0.2
1.2 ± 0.0
0.4 ± 0.0

1.2 ± 0.4
18.0 ± 1.6
0.3 ± 0.0
1.4 ± 0.1
1.8 ± 0.4
0.9 ± 0.2

0.7 ± 0.2
43.4 ± 14.7
0.4 ± 0.0
1.3 ± 0.3
1.6 ± 1.7
0.7 ± 0.2

0.7 ± 0.2
1.8 ± 0.4
0.0 ± 0.0
0.8 ± 0.1
8.9 ± 2.5
0.3 ± 0.0

41.05 ± 5.3
2,083 ± 370
750 ± 149
21.7 ± 1.3
5,7300 ± 8,261
14.7 ± 1.8

Mice (n = 3 per group) were injected with either alum alone or alum + KLH on days 0, 14, and 28; DRG neurons were isolated 24 h after the last injection as described in the Section
“Materials and Methods.” RNA was isolated from resultant DRG neurons, as well as from DRG neurons and spleens harvested from naïve mice. Gene expression was analyzed by
qPCR. Data are shown as relative fold changes (mean ± SD) normalized to alum-injected group. Results reveal the lack of Rag1, Aicda, and Ung in DRG neurons across time points
and the presence of gene expression in the Naïve spleen.

FIGURE 3 | In vitro stimulated splenic B cells, but not dorsal root ganglion (DRG) sensory neurons, express B cell activation markers associated with antibody
synthesis. Naïve splenic B cells stimulated in vitro for 24–72 h with LPS + IL-4 (A) or anti-CD40 + IL-4 (B) express genes associated with antibody production (Rag2
and Aicda), as well as Prdm1, a marker of activated B cells/plasma cells. Stimulated B cells are compared to naïve freshly isolated, untreated B cells. In contrast,
DRG neurons stimulated in vitro with LPS + IL-4 (C) and anti-CD40 + IL-4 (D) for up to 120 h do not exhibit gene expression associated with antibody production
(Rag2 and Aicda) or Prdm1 when compared to untreated DRG neurons. Stimulated DRG neurons are compared to vehicle-treated cells at each time point. Data are
shown as mean ± SD quantitative PCR (qPCR) data for duplicate samples.

(Figures 6A,B). Next, we generated chimeric mice by transferring Rag1 KO BM to WT mice or WT BM to Rag1 KO mice.
After confirming the reconstitution of the recipient animals
(data not shown), the chimeric mice received alum injections or
alum + KLH immunizations as described. Immunohistochemical
analysis of chimeric mice with Rag1-deficient BM (Rag1negative hematopoietic cells, but Rag1-positive DRG sensory

antibodies would contain no antigen-specific antibodies. To
address this question, we utilized mice with a homozygous targeted
disruption of the membrane exon of the Ig mu-chain (μMT mice)
that are deficient of mature peripheral B cells as well as Rag1 KO
mice that do not produce mature T and B lymphocytes (28–30).
Immunohistochemical analysis revealed that DRGs from either
μMT or Rag1 KO mice do not contain antigen-specific antibodies
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alum + KLH-immunized groups (Figures 7B,C). In contrast,
IgG-positive neuronal populations were observed in DRGs from
alum-injected chimeric mice with WT BM (Rag1-positive hematopoietic cells, Rag1-negative sensory neurons) (Figure 7D).
Furthermore, immunization with alum + KLH significantly
increased the number of IgG-positive sensory neurons in the
DRGs as observed with WT mice (Figures 7E,F).
We next analyzed the immunoglobulin release by DRG sensory neurons from chimeric mice using both total IgG and KLHspecific IgG ELISpot assays. Increased IgG-positive neuronal
cells are observed in the DRGs harvested from chimeric mice
with WT BM, but not in the chimeric mice with Rag1-deficient
BM (Figure 8A). Analysis of KLH-specific IgG-releasing cells
revealed a significant increase in anti-KLH IgG-positive DRG
sensory neurons in the DRGs isolated from alum + KLHimmunized chimeric mice with WT BM (Figure 8B). In
contrast, no anti-KLH IgG-secreting DRG sensory neurons are
observed in immunized chimeric mice with Rag1-deficient BM
(Figure 8B). Administration of alum alone also increased the
number of total IgG-releasing DRG sensory neurons, but not
anti-KLH IgG-positive neurons (Figures 8A,B). Together, these
data suggest that DRG sensory neurons not only sequester and
retain antibodies secreted by plasma B cells but also can release
these antibodies.

neurons) revealed that in the absence of antibody secreting
plasma cells, no IgG reactivity is observed in sensory neurons
from DRGs isolated from either alum-injected (Figure 7A) or

FIGURE 4 | Mouse dorsal root ganglion (DRG) neurons lack Igγ1 chain
expression. Immunohistochemical staining of spleen and whole DRGs
isolated from alum + KLH-immunized mice expressing tdTomato under
the control of the Ighg1 promoter. (A) Spleens express Igγ1 chain (red)
(DAPI = blue). (B) DRG neurons express NeuN (gray) and IgG (green),
but not Igγ1 chain (red; tdTomato) (DAPI = blue). 400× magnification;
scale bar = 20 µm.

FIGURE 5 | Dorsal root ganglion (DRG) neurons from mice lacking neuronal-specific Rag2 expression contain antigen-specific antibodies. Immunohistochemical
staining of whole DRGs isolated from alum-injected (A) and alum + KLH-immunized (B) neuronal–specific Rag2 knock-out (KO) mice for IgG (green), neurons
(NeuN, red), and nuclei (DAPI, blue). 400× magnification; scale bar = 20 µm. (C) Quantitation of IgG-releasing DRG neurons isolated from alum-injected and
alum + KLH-immunized neuronal-specific Rag2 KO mice using the ELISpot assay (mean ± SD, n = 4 per group); *P < 0.05 vs. alum-injected (Mann-Whitney test).
(D) Quantification of anti-KLH-specific IgG immunospots from DRG neurons isolated from alum-injected and alum + KLH-immunized neuronal-specific Rag2 KO
mice (mean ± SD, n = 4 per group) using the antigen-specific ELISpot assay *p < 0.05 vs. alum-injected (Mann-Whitney test).
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DISCUSSION
Here we demonstrate that antigen-specific antibodies are sequestered in mouse DRG sensory neurons. A significantly higher
number of DRG sensory neurons from immunized animals
showed sequestration of antigen-specific antibodies as compared
to alum-injected control or naïve mice. RNA-seq analysis and
qPCR of the neuronal transcripts revealed that sensory neurons
from DRGs lack the genetic machinery to produce antibodies.
Using transgenic and chimeric animals, we further confirmed
that DRG sensory neurons do not synthesize antigen-specific
antibodies, but sequester the antibodies released by plasma cells.
As shown in Figure 1, DRG neurons isolated from naive
mice and alum-injected mice had similar low percentages of
IgG-containing NeuN+ neurons (~4–6%), while DRG neurons
isolated from mice immunized with alum + KLH showed significantly higher percentages (~24%). Antibody localization appears

FIGURE 6 | Dorsal root ganglion (DRG) neurons from mice deficient in
B cell-derived IgGs [μMt and Rag1 knock out (KO)] lack antigen-specific IgG
immunoreactivity. Immunohistochemical staining of whole DRGs isolated from
alum + KLH-immunized μMt (A) and Rag1 KO (B) mice stained for neurons
(NeuN, red), IgG (green), and nuclei (DAPI, blue), 400× magnification; scale
bar = 20 µm.

FIGURE 7 | Dorsal root ganglion (DRG) neurons from chimeric mice with Rag1 knock out (KO) BM lack immunization-induced antibody accumulation.
Immunostaining of whole DRGs isolated from alum-injected (A) and alum + KLH-immunized (B) chimeric mice (Rag1 KO BM to WT) for neurons (NeuN, red),
IgG (green), and nuclei (DAPI, blue). 400× magnification; scale bar = 20 µm. (C) Percentage of double IgG-positive, NeuN-positive neurons (among total NeuNpositive neurons) in DRGs from isolated from alum-injected and alum + KLH-immunized chimeric mice (Rag1 KO BM into WT mice); data are shown as mean
percentage ± SD; (n = 5 per group). Immunostaining of whole DRGs isolated from alum-injected (D) and alum + KLH-immunized (E) chimeric mice (WT BM into
Rag1 KO) for neurons (NeuN, red), IgG (green), and nuclei (DAPI, blue). 400× magnification; scale bar = 20 µm. (F) Percentage of double IgG-positive, NeuNpositive neurons (among total NeuN-positive neurons) in DRGs isolated from alum-injected and alum + KLH-immunized chimeric mice (WT BM to Rag1 KO);
(mean percentage ± SD, n = 6 per group). **P < 0.05 vs. alum-injected (Mann-Whitney test).
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FIGURE 8 | Dorsal root ganglion (DRG) sensory neurons from mice with Rag1-positive hematopoietic cells, but not from mice with Rag1-negative hematopoietic
cells, release antigen-specific IgG. Detection of IgG-releasing cells using the ELISpot assay. Quantification of (A) total IgG and (B) anti-KLH-specific IgG
immunospots produced by DRG neurons isolated from alum-injected and alum + KLH-immunized chimeric mice [Rag1 knock-out (KO) bone marrow (BM)
into wild-type (WT) and WT BM into Rag1 KO]. (Mean ± SD, n = 4 per group). *P < 0.05 vs. alum-injected (Mann-Whitney test).

intracellular. However, the subcellular localization of IgG within
NeuN+ DRG neurons remains to be determined. All additional
experiments included the alum-injected and alum + KLHimmunized groups. Although this study design limited our ability
to compare DRG neurons obtained from naive vs. alum-treated
mice, it focused our studies on assessing antigen-specific antibody responses in alum-injected vs. alum + KLH-immunized
mice. The anti-KLH antibodies released by DRG neurons were
primarily IgG1 (not IgG2 or IgG3) (Figure 2D). We did not assay
for IgA, IgE, or IgM antibodies. Future studies will examine what
stimuli (e.g., antigen, capsaicin, or KCl) trigger IgG release by
DRG neurons.
Antibodies are normally synthesized by mature plasma cells.
However, recent accumulating evidence suggests that nonlymphoid cells, such as human sperm (31), hepatocytes (32),
certain carcinoma cells (25, 32, 33), and neurons from the central
nervous system (34–37), also express genes required for antibody
synthesis and produce antibodies. Here, we demonstrate that
although DRG sensory neurons exhibit localization of antigenspecific antibodies, the neuronal cells do not express the essential
enzymes required for generating antibody diversity. V(D)J
recombination is tightly regulated during B cell differentiation
by transcriptional regulation of lymphoid-specific recombinase
genes encoding RAG1 and RAG2 enzymes (38–41). In mature
B cells, antigenic stimulation induces somatic hypermutation,
gene conversion, and class switch recombination leading to generation of a secondary repertoire of high-affinity antigen-specific
antibodies (42, 43). Activation-induced cytidine deaminase
(AID), an enzyme encoded by the Aicda gene, is responsible for
regulating and coordinating these three genetic rearrangements
in mature B cells (42, 44). AID generates antibody diversity by
converting cytosine to uracil within the immunoglobulin loci
resulting in mismatch mutations. The uracil-guanine mismatch
created by AID is repaired by uracil-DNA glycosylase (UNG),
a DNA-repair enzyme encoded by the gene Ung, introducing
base-pair changes resulting in antibody diversity (42). The DRG
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neuronal transcriptome analysis here revealed the absence of
Rag1, Rag2, Aicda, and Ung transcripts. Furthermore, in vitro
activation of DRG sensory neurons with LPS and IL-4 (to induce
T-independent class switch recombination) or anti-CD40 and
IL-4 (to induce T-dependent class switch recombination) did not
induce significant increases in expression of either Rag1, Rag2,
Aicda, or Ung genes. Moreover, a comprehensive transcriptome
analysis of 622 hand-picked single neurons harvested from
lumbar DRGs of naïve mice showed no detectable Rag1, Rag2, or
Aicda expression (16).
An interesting finding in the current study is the marked
discordance in the expression of Rag1 and Rag2 transcripts
in DRG sensory neurons harvested from immunized mice.
Amplification of the neuronal transcripts showed low levels of
Rag2 but no Rag1 transcripts present in DRG sensory neurons. It
is unlikely that DNA contamination contributed to the results, as
all samples were treated with DNase before analysis, and intron
spanning primers were used. These data rather suggest that Rag1
and Rag2 are differentially expressed in immunized mice. As discussed earlier, expression of Rag1 and Rag2 is tightly controlled
and occurs primarily during the early developmental stages of T
and B cells. A cis-regulatory element located in the RAG locus
regulates coordinated expression of Rag1 and Rag2. However, a
less-strict control of transcription within the RAG locus results
in functionless expression of Rag2 transcript in the brain and
other non-lymphoid tissues (27). Although expression of Rag1
and Rag2 transcripts have been reported in a variety of nonlymphoid cells, including different cancer cell types, epithelial
cells and neurons (34, 45, 46), to our knowledge, no functional
role for these enzymes have been identified in non-lymphoid
cells.
In order to investigate the functional role of the RAG2 enzyme
for antibody synthesis in neurons, we developed a neuronspecific Rag2 KO mouse to detect if antibodies are sequestered
in neurons in the absence of neuronal Rag2 gene expression. We
immunized the neuronal Rag2 KO mice with alum + KLH and
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observed a significant increase in antibody sequestration, total
IgG and anti-KLH IgG-releasing neurons in DRGs from immunized mice even in the absence of Rag2 expression in neurons.
Mice deficient in either RAG1 or RAG2 enzymes lack mature
lymphocytes and fail to generate antibodies due to their inability
to initiate V(D)J rearrangement (30, 47). In the absence of V(D)
J recombination and mature B cells, Rag1 KO mice completely
lacked antibody localization in their DRG sensory neurons.
Consistent with this observation, no localization of antibodies
was observed in mice homozygous for an inactivating mutation
of the membrane exon of their immunoglobulin μ chain gene
(μMT) that results in mature B cell deficiency and no antibody
production (29). Adoptive transfer of WT BM into Rag1-deficient
mice restored antibody sequestration in DRGs. Together, these
results indicate that DRG sensory neurons sequester antibodies
released by mature B cells.
Antibody accumulation has been described in brain tissues
and cerebrospinal fluid in both healthy and pathological conditions (35, 37, 48, 49). Antigen-antibody immune complexes
directly activate sensory neurons resulting in an increase in
intracellular calcium (9, 50), initiation of action potentials (8, 50),
and the release of neurotransmitters from DRG neurons (9).
The presence of antibodies in the nervous system could be
attributed to receptor-mediated uptake of antibodies by neurons.
Immunoglobulin G and its receptors have been observed in
the human nervous system (34), rodent brains (9, 35, 37, 51),
and zebrafish sensory neurons (24, 46). Expression of different
subtypes of Fcγ receptors have been shown in Purkinje cells,
parvalbumin neurons, primary neuronal cultures, and sensory
neurons (52–54). While RNA-seq and qPCR (data not shown)
failed to detect the expression of either Fcgr1 or Fcgr3 in DRG
sensory neurons, the expression of one Fcgr2b variant and Fcgrt
were detected (Table 2). Consistent with our data, single cell
analysis of the DRG neuron transcriptome revealed a lack of
expression of Fcγ receptors 1 and 3 (16). However, the presence
of FcRn, an MHC class I related antibody receptor, has been
detected in sensory neurons (16). FcRn, a product of the Fcgrt
gene, plays a pivotal role in passively transferring IgG within
and across multiple cell types (55–59) and protecting IgG from
degradation (59–61). Mice genetically deficient in Fcgrt (lacking
FcRn) have significantly reduced plasma half-life of IgG and
exhibit hypogammaglobulinemia (60–62). In the central nervous
system, FcRn expressed by endothelial cells has been implicated
in antibody transport across the blood brain barrier (63). Similar
to the situation in the central nervous system, it is possible that
in DRGs, FcRn mediates the transport of antibodies into sensory
neurons and protects the IgGs from degradation within the neuronal cells. Further studies are required to address the functions
of Fcγ receptors and FcRn in peripheral DRG sensory neurons.
Future studies using in vitro and in vivo methods including single
cell qPCR (to compare neurons that sequester IgG vs. those that
do not) will provide insight on how and why antigen-specific
antibodies are taken up by DRG neurons.
Several possibilities exist that may explain the accumulation
of antibodies in sensory neurons. Antibody uptake by neurons
may have a self-protecting effect. Using a murine stroke model,
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Arumugam et al have demonstrated that intravenously injected
IgG protects the brain against neuronal death by neutralizing
the effects of complement (64). In a mouse model of Alzheimer’s
disease, antibodies assisted clearance of amyloid β-peptide from
the CNS into the circulation via FcRn (65). Antigen-specific
antibodies also aid in clearance of neuronal-specific pathogens
from neurons. Treatment of encephalitis virus-infected primary
cultured neurons with virus-specific antibodies clears the
infectious encephalitis virus from neurons by restricting viral
gene expression (66). Accordingly, immunodeficient scid mice
infected with the encephalitis virus develop persistent non-lethal
central nervous system infection (66). It is also possible that invading pathogens get opsonized by the locally released antibodies
and are subsequently phagocytosed by glial cells (67). In addition,
antigen-antibody complexes may mediate hyperalgesia by activating peripheral sensory neurons. Numerous antigen-specific
immune-related disorders are often accompanied by pain. These
disorders include autoimmune diseases such as rheumatoid
arthritis (68) and Guillain-Barre syndrome (69), viral reactivation
syndromes such as herpes zoster (70, 71), and allergic diseases
such as atopic and allergic contact dermatitis (72, 73). Elevated
levels of antigen-specific antibodies, especially IgG, and immune
complexes are found in the serum and affected tissues in these
diseases. Immune complexes directly activate nociceptive DRG
neurons in a TRPC3-receptor dependent manner, and increase
neuronal excitability and thus, potentially contribute to pain (7, 8).
Recent studies have demonstrated that intradermal injection of
immune complexes dose-dependently produces mechanical and
thermal hyperalgesia in the hind paws of rats that can be alleviated by localized administration of non-specific antibody (74).
Finally, it is important to note that our studies were confined to
DRG sensory neurons. We did not study other sensory neurons
(e.g., nodose or trigeminal ganglia).
Our studies demonstrate that peripheral DRG sensory neurons sequester antibodies made by plasma cells. In concluding
that DRG neurons do not produce antibodies we are at risk of
a type II error (in failing to reject a null hypothesis that is actually false). We have attempted to reduce the risk of this error by
analyzing large numbers of DRG neurons from the mice and
by testing the same hypothesis using multiple approaches and
models [qPCR, RNA-seq, immunostaining, and both in vitro
and in vivo models (using multiple genetically modified mice and
BM transfer techniques)]. Therefore, we are confident that our
results demonstrate that DRG neurons sequester antigen-specific
antibodies. These antigen-specific antibodies may play an important role in protecting DRG neurons from pathogen-induced
damage, or in inducing antigen-specific hyperalgesia. These
findings, together with the previous studies, implicate immune
complexes in mediating neuro-immune crosstalk between DRG
sensory neurons and antibodies in both physiological and pathological conditions.
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